{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:17:02Z","timestamp":1792005422923,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11030-020-10130-1","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T10:04:10Z","timestamp":1596189850000},"page":"383-401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach"],"prefix":"10.1007","volume":"25","author":[{"given":"Ashish M.","family":"Kanhed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dushyant V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya M.","family":"Teli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirav R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh T.","family":"Chhabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mange Ram","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"10130_CR1","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1038\/nm1143","volume":"10","author":"JSM Peiris","year":"2004","unstructured":"Peiris JSM, Guan Y, Yuen KY (2004) Severe acute respiratory syndrome. Nat Med 10:S88\u2013S97","journal-title":"Nat Med"},{"key":"10130_CR2","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","volume":"367","author":"AM Zaki","year":"2012","unstructured":"Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814\u20131820","journal-title":"N Engl J Med"},{"key":"10130_CR3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","volume":"395","author":"C Wang","year":"2020","unstructured":"Wang C, Horby PW, Hayden FG, Gao GF (2020) A novel coronavirus outbreak of global health concern. Lancet 395:470\u2013473","journal-title":"Lancet"},{"key":"10130_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497\u2013506","journal-title":"Lancet"},{"key":"10130_CR5","doi-asserted-by":"crossref","unstructured":"Woelfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Mueller MA et al (2020) Clinical presentation and virological assessment of hospitalized cases of coronavirus disease 2019 in a travel-associated transmission cluster. medRxiv. 2020.03.05.20030502","DOI":"10.1101\/2020.03.05.20030502"},{"key":"10130_CR6","first-page":"157","volume":"91","author":"D Cucinotta","year":"2020","unstructured":"Cucinotta D, Vanelli M (2020) WHO declares COVID-19 a pandemic. Acta Biomed 91:157\u2013160","journal-title":"Acta Biomed"},{"key":"10130_CR7","unstructured":"World Health Organization (2020) Coronavirus disease 2019 (COVID-19) situation report-89. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200418-sitrep-89-covid019.pdf?sfvrsn=3643dd38_2. Accessed April 19, 2020"},{"key":"10130_CR8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jmv.25681","volume":"92","author":"Y Chen","year":"2020","unstructured":"Chen Y, Liu Q, Guo D (2020) Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92:418\u2013423","journal-title":"J Med Virol"},{"key":"10130_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","volume":"17","author":"J Cui","year":"2019","unstructured":"Cui J, Li F, Shi ZL (2019) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17:181\u2013192","journal-title":"Nat Rev Microbiol"},{"key":"10130_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2014.00296","volume":"5","author":"TS Fung","year":"2014","unstructured":"Fung TS, Liu DX (2014) Coronavirus infection, ER stress, apoptosis and innate immunity. Front Microbiol 5:1\u201313","journal-title":"Front Microbiol"},{"key":"10130_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathogens9030186","volume":"9","author":"HM Ashour","year":"2020","unstructured":"Ashour HM, Elkhatib WF, Rahman MM, Elshabrawy HA (2020) Insights into the recent 2019 novel coronavirus (Sars-coV-2) in light of past human coronavirus outbreaks. Pathogens 9:1\u201315","journal-title":"Pathogens"},{"key":"10130_CR12","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1099\/vir.0.19424-0","volume":"84","author":"V Thiel","year":"2003","unstructured":"Thiel V, Ivanov KA, Putics \u00c1, Hertzig T, Schelle B, Bayer S et al (2003) Mechanisms and enzymes involved in SARS coronavirus genome expression. J Gen Virol 84:2305\u20132315","journal-title":"J Gen Virol"},{"key":"10130_CR13","doi-asserted-by":"crossref","unstructured":"Zhang L, Lin D, Sun X, Rox K, Hilgenfeld R (2020) X-ray structure of main protease of the novel coronavirus SARS-CoV-2 enables design of \u03b1-ketoamide inhibitors. bioRxiv (Internet). 2020.02.17.952879","DOI":"10.1101\/2020.02.17.952879"},{"key":"10130_CR14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y et al (2020) Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature 582:286\u2013293","journal-title":"Nature"},{"key":"10130_CR15","doi-asserted-by":"crossref","unstructured":"Adem S, Eyupoglu V, Sarfraz I, Rasul A, Ali M (2020) Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: an in silico strategy unveils a hope against CORONA. Preprints (internet). 2020030333","DOI":"10.20944\/preprints202003.0333.v1"},{"key":"10130_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2020.03.009","author":"MT ul Qamar","year":"2020","unstructured":"ul Qamar MT, Alqahtani SM, Alamri MA, Chen L-L (2020) Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal. https:\/\/doi.org\/10.1016\/j.jpha.2020.03.009","journal-title":"J Pharm Anal"},{"key":"10130_CR17","unstructured":"Rut W, Groborz K, Zhang L, Sun X, Zmudzinski M, Hilgenfeld R et al (2020) Substrate specificity profiling of SARS-CoV-2 Mpro protease provides basis for anti-COVID-19 drug design. bioRxiv. 2020.03.07.981928"},{"key":"10130_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1021\/acscentsci.0c00272","volume":"6","author":"C Liu","year":"2020","unstructured":"Liu C, Zhou Q, Li Y, Garner LV, Watkins SP, Carter LJ et al (2020) Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Cent Sci 6:315\u2013331","journal-title":"ACS Cent Sci"},{"key":"10130_CR19","doi-asserted-by":"publisher","first-page":"D1137","DOI":"10.1093\/nar\/gkx1088","volume":"46","author":"VB Siramshetty","year":"2018","unstructured":"Siramshetty VB, Eckert OA, Gohlke BO, Goede A, Chen Q, Devarakonda P et al (2018) SuperDRUG2: a one stop resource for approved\/marketed drugs. Nucl Acids Res 46:D1137\u2013D1143","journal-title":"Nucl Acids Res"},{"key":"10130_CR20","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1093\/bioinformatics\/bti295","volume":"21","author":"A Goede","year":"2005","unstructured":"Goede A, Dunkel M, Mester N, Frommel C, Preissner R (2005) Super drug: a conformational drug database. Bioinformatics 21:1751\u20131753","journal-title":"Bioinformatics"},{"key":"10130_CR21","unstructured":"Asinex. http:\/\/www.asinex.com. Accessed on April 05, 2020"},{"key":"10130_CR22","unstructured":"Protein Preparation Wizard; Epik, Schr\u00f6dinger, LLC, New York, NY, 2016; Impact, Schr\u00f6dinger, LLC, New York, NY, 2016; Prime, Schr\u00f6dinger, LLC, New York, NY, 2020"},{"key":"10130_CR23","unstructured":"ClinicalTrials. https:\/\/clinicaltrials.gov. Accessed April 10, 2020"},{"key":"10130_CR24","unstructured":"Protein Data Bank. www.rcsb.org\/pdb\/home\/home.do"},{"key":"10130_CR25","unstructured":"LigPrep, Schr\u00f6dinger, LLC, New York, NY, 2020"},{"key":"10130_CR26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10822-009-9268-1","volume":"23","author":"K Loving","year":"2009","unstructured":"Loving K, Salam NK, Sherman W (2009) Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation. J Comput Aided Mol Des 23:541\u2013554","journal-title":"J Comput Aided Mol Des"},{"key":"10130_CR27","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1021\/ci900212v","volume":"49","author":"NK Salam","year":"2009","unstructured":"Salam NK, Nuti R, Sherman W (2009) Novel method for generating structure-based pharmacophores using energetic analysis. J Chem Inf Model 49:2356\u20132368","journal-title":"J Chem Inf Model"},{"key":"10130_CR28","unstructured":"Glide, Schr\u00f6dinger, LLC, New York, NY, 2020"},{"key":"10130_CR29","unstructured":"Lindahl, Abraham, Hess, van der Spoel, GROMACS 2020.1 Source code (Version 2020.1). Zenodo. http:\/\/doi.org\/10.5281\/zenodo.3685919. Access on March 3, 2020"},{"key":"10130_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang J, Rauscher S, Nawrocki G, Ran T, Feig M, De Groot BL, Grubm\u00fcller H, MacKerell AD (2017) CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat Methods 14:71\u201373","journal-title":"Nat Methods"},{"key":"10130_CR31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","volume":"31","author":"K Vanommeslaeghe","year":"2009","unstructured":"Vanommeslaeghe K, Acharya C, Kundu S, Zhong S, Shim J, Darian E, Guvench O, Lopes P, Vorobyov I, Mackerell AD Jr (2009) CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM ALL-atom additive biological force fields. J Comput Chem 31:671\u2013690","journal-title":"J Comput Chem"},{"key":"10130_CR32","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1002\/jcc.23067","volume":"33","author":"W Yu","year":"2012","unstructured":"Yu W, He X, Vanommeslaeghe K, MacKerell AD (2012) Extension of the CHARMM general force field to sulfonyl-containing compounds and its utility in biomolecular simulations. J Comput Chem 33:2451\u20132468","journal-title":"J Comput Chem"},{"key":"10130_CR33","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark P, Nilsson L (2001) Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J Phys Chem A 105:9954\u20139960","journal-title":"J Phys Chem A"},{"key":"10130_CR34","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/0040-4020(67)85023-3","volume":"2","author":"M Bixon","year":"1967","unstructured":"Bixon M, Lifson S (1967) Potential functions and conformations in cycloalkanes. Tetrahedron 2:769\u2013784","journal-title":"Tetrahedron"},{"key":"10130_CR35","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden T, York D, Pedersen L (1993) Particle mesh Ewald: an N\u00a0log(N) method for Ewald sums in large systems. J Chem Phys 98:10089\u201310092","journal-title":"J Chem Phys"},{"key":"10130_CR36","unstructured":"XMgrace. http:\/\/plasma-gate.weizmann.ac.il\/Grace\/"},{"key":"10130_CR37","unstructured":"Rawat R, Verma SM (2020) HeroMDAnalysis: an automagical tool for MD simulation analysis. http:\/\/www.heromdanalysis.wordpress.com"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-020-10130-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-020-10130-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-020-10130-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T03:52:46Z","timestamp":1723348366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-020-10130-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10130"],"URL":"https:\/\/doi.org\/10.1007\/s11030-020-10130-1","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]},"assertion":[{"value":"5 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}